Once PIM1 was selected as a promising candidate for further studies, we verified the ability of the JAK3Q988P mutation to induce PIM1 overexpression in different T-ALL/LBL cell lines (Supplementary Fig. 1a). Here, PIM1 is linked to acute lymphoblastic leukemia.